Efficacy and safety of a 3-month dosing regimen of degarelix in Japanese patients with prostate cancer: a phase II maintenance-dose-finding study
Seiichiro Ozono; Taiji Tsukamoto; Seiji Naito; Yasuo Ohashi; Takeshi Ueda; Tsutomu Nishiyama; Hideki Maeda; Hidehito Kusuoka; Rio Akazawa; Mototsugu Ito; Hideyuki Akaza
Author Information: Department of Urology, Hamamatsu University School of Medicine, Shizuoka
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.